Novartis reported 9.96B in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Alcon AG ALC:SW 1.94B 24M
Amgen AMGN:US $ 3.74B 804M
Artemis Alpha ATS:LN 872K 40K
AstraZeneca AZN:LN 10.51B 1.79B
Bayer BAYN:GR 10.43B 1.33B
Biogen BIIB:US $ 1921.1M 225.6M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Eli Lilly And LLY:US $ 5405.7M 677M
Fresenius FRE:GR 8.82B 25M
Fresenius Medical Care FME:GR 4.2B 2.83M
Galapagos GLPG:NA 165.17M 9.07M
Genmab GEN:DC 1.61B 205M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.5B 550M
Hikma Pharmaceutical HIK:LN 1.08B 209M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Lonza Group LONN:SW 2.33B 108M
Merck MRK:GR 4.03B 149M
Merk MRK:US $ 10332M 386M
Novartis NOVN:VX 9.96B 998M
Novartis NVS:US 9.96B 998M
Orion ORNBV:FH 199.1M 37.5M
Pfizer PFE:US $ 15788M 3271M
Philips PHIA:NA € 4099M 683M
Recordati REC:IM 288.11M 18.51M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M